Ryan Fukushima Sells 23,818 Shares of Tempus AI (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 23,818 shares of the stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $46.19, for a total transaction of $1,100,153.42. Following the transaction, the chief executive officer owned 143,945 shares in the company, valued at $6,648,819.55. The trade was a 14.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00.
• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The shares were sold at an average price of $44.07, for a total transaction of $597,148.50.

Tempus AI Trading Down 0.7%

Shares of TEM stock traded down $0.35 on Wednesday, hitting $46.70. 3,489,060 shares of the company’s stock traded hands, compared to its average volume of 5,862,125. The stock has a market capitalization of $8.39 billion, a price-to-earnings ratio of -32.43 and a beta of 3.58. The company’s fifty day simple moving average is $51.41 and its 200 day simple moving average is $52.28. Tempus AI, Inc. has a one year low of $40.77 and a one year high of $104.32. The company has a debt-to-equity ratio of 3.06, a quick ratio of 3.16 and a current ratio of 3.30.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The business had revenue of $382.49 million during the quarter, compared to the consensus estimate of $379.69 million. During the same period in the previous year, the firm posted ($0.22) earnings per share. The firm’s revenue for the quarter was up 21.6% on a year-over-year basis. Equities analysts forecast that Tempus AI, Inc. will post -1.35 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on TEM shares. Jefferies Financial Group initiated coverage on Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 target price for the company. TD Cowen reiterated a “buy” rating on shares of Tempus AI in a research report on Wednesday, July 15th. Wolfe Research began coverage on shares of Tempus AI in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 target price on shares of Tempus AI in a research note on Friday, July 31st. Finally, HC Wainwright lowered their price target on shares of Tempus AI from $64.00 to $56.00 and set a “buy” rating for the company in a report on Monday. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $64.92.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. JPL Wealth Management LLC bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $26,000. Los Angeles Capital Management LLC bought a new position in shares of Tempus AI during the fourth quarter valued at approximately $27,000. Harvest Fund Management Co. Ltd purchased a new stake in Tempus AI in the third quarter worth $38,000. Whittier Trust Co. boosted its holdings in Tempus AI by 190.0% in the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after acquiring an additional 570 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Tempus AI by 88.8% in the second quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock valued at $44,000 after acquiring an additional 325 shares in the last quarter. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.